NSE filing, NSE: FRACTAL. Summary written from the filing by ALFA Finder's alert engine.
Fractal Analytics Ltd: key numbers
- Share price
- ₹750.00
- Market cap
- ₹13,058 Cr
- Revenue (annual)
- ₹3,300 Cr
- Net profit (annual)
- ₹292.2 Cr
- P/E (TTM)
- 39.7×Sector 23.0×
- Promoter holding
- 16.81%-0.16% QoQ
- FII holding
- 40.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fractal Analytics Ltd
All →Fractal Analytics Price Movement Clarification
Fractal Analytics clarified BSE's query on recent volume spikes, stating no undisclosed price-sensitive information exists. The company attributed the movement to prevailing market conditions.
Fractal Analytics Management Change
Fractal Analytics appointed Shilpa Kedia as CFO effective October 19, 2026, replacing Ashwath Bhat who resigned. The revised authorised KMP list was filed under Regulation 30(5).
Fractal Analytics Other Announcement
Fractal Analytics Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Fractal Analytics Management Change
Fractal Analytics appointed Mr. Vivek Mohan as Chairman, following Mr. Rohan Haldea's cessation from the role, both effective October 9, 2026.
Fractal Analytics Merger & Restructuring
Fractal Analytics Limited incorporated a new step-down subsidiary, FRACTAL AI QFZ LLC, in Qatar Free Zones to expand its software and AI consultancy services.
Fractal Analytics Other Announcement
Fractal Analytics filed the quarterly confirmation certificate required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, as received from its registrar.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date